Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

Clinical Reviews in Allergy & Immunology

Issue 3/2005

Content (22 Articles)

Intravenous immunoglobulin

Yehuda Shoenfeld, M. Eric Gershwin

Intravenous immunoglobulin in immunodeficiency states

Elias Toubi, Amos Etzioni

Intravenous immunoglobulin

Hedi Orbach, Uriel Katz, Yaniv Sherer, Yehuda Shoenfeld

Facing the enigma of immunomodulatory effects of intravenous immunoglobulin

Tal Sapir, Yehuda Shoenfeld

Intravenous immunoglobulin and dendritic cells

Namita Misra, Jagadeesh Bayary, Sooryasarathi Dasgupta, Amal Ephrem, Jean-Paul Duong Van Huyen, Sandrine Delignat, Gazzala Hassan, Giuseppina Caligiuri, Antonino Nicoletti, Sebastien Lacroix-Desmazes, Michel D. Kazatchkine, Srini V. Kaveri

Anti-inflammatory effect of intravenous immunoglobulin mediated through modulation of complement activation

Hans U. Lutz, Peter J. Späth

Toward molecular targeting with specific intravenous immunoglobulin preparation

Miri Blank, Israel Nur, Orgad Toub, Anabel Maor, Yehuda Shoenfeld

Intravenous immunoglobulin therapy and systemic lupus erythematosus

Gisele Zandman-Goddard, Yair Levy, Yehuda Shoenfeld

Intravenous immunoglobulin therapy in antiphospholipid syndrome

Emiliana Konova

Intravenous immunoglobulin therapy in vasculitis

Peer Malte Aries, Bernhard Hellmich, Wolfgang Ludwig Gross

Intravenous immunoglobulin and multiple sclerosis

Anat Achiron, Shmuel Miron

Intravenous immunoglobulin in patients with anti-GAD antibody-associated neurological diseases and patients with inflammatory myopathies

Marinos C. Dalakas

Intravenous immunoglobulin in therapy of peripheral neuropathy

Alexander Gorshtein, Yair Levy

Intravenous immunoglobulin and guillain-barré syndrome

Michal Harel, Yehuda Shoenfeld

Intravenous immunoglobulin for treatment of pemphigus

Lehavit Akerman, Daniel Mimouni, Michael David

Intravenous immunoglobulin in eye involvement

Zera Tellier

Uncovering the hidden potential of intravenous immunoglobulin as an anticancer therapy

Tal Sapir, Yehuda Shoenfeld

Intravenous immunoglobulin and atherosclerosis

Eiji Matsuura, Kazuko Kobayashi, Katsumi Inoue, Yehuda Shoenfeld

Intravenous immunoglobulin and fibrosis

Vered Molina, Miri Blank, Yehuda Shoenfeld

Intravenous immunoglobulin and recurrent pregnancy loss

Howard J. A. Carp, Tal Sapir, Yehuda Shoenfeld

Virus safety of intravenous immunoglobulin

Nicola Boschetti, Martin Stucki, Peter J. Späth, Christoph Kempf

Erratum

Making the diagnosis of asthma in the athlete

Christopher Randolph

Oct 05
Issue: 2/2005
Feb 06
Issue: 1/2006

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits